Parties weigh-in on assisted suicide exemption as court
Parties weigh-in on assisted suicide exemption as court decision looms
With a court ruling expected in weeks, conscientious health care professionals say they should not be forced to counsel or aid patients who want to commit medical suicide.
In July, a medical ethics group and a Christian doctors’ group sued members of the Vermont Board of Medical Practice and other state officials over Vermont’s assisted suicide law, Act 39.
The plaintiffs, Vermont Alliance for Ethical Healthcare and the Christian Medical and Dental Associations, filed their suit in the U.S. District Court for the District of Vermont.
The groups claim that a mandate requiring any participation assisted suicide would violate the religious beliefs of some medical professionals, and that those professionals should be allowed to make conscientious decisions without the threat of disciplinary action or civil or criminal proceedings.
“It’s medically inappropriate for a doctor to be forced to council a patient to take their own life. My clients affirm the sanctity and value of their patients, and the court will have to determine whether that is adequate,” Steven Aden, the plaintiffs’ senior counsel, told Watchdog.
Aden is a member of Alliance for Defending Freedom, an organization that specializes in religious liberty and free speech cases. He told Watchdog he expects a ruling in the next two weeks.
Act 39, Vermont’s assisted suicide law, was signed into law in 2013 by Gov. Peter Shumlin. While the law offers limited protection for medical professionals who object on religious or moral grounds, plaintiffs say the Vermont Department of Health has circumvented those exemptions by requiring them to mention assisted suicide as an option in discussions over palliative care. If a patient then decides to take action to commit suicide, those doctors can refer the patient to another doctor for life-ending prescription.
Linda Waite-Simpson, Vermont state director of Compassion and Choices, a national organization that advocates for medical aid in dying, says all practicing doctors should be required to counsel patients about assisted suicide.
“It’s important at every step to talk about all options. Doctors should do everything they can to make sure patients are not suffering,” Waite-Simpson told Vermont Watchdog.
Asked why every Vermont doctor should be required to participate, Waite-Simpson said, “At such a vulnerable time, I would want to have this conversation with my doctor. No one else.”
The central issue of the case is what constitutes participation. The plaintiffs argue that counseling suicide and writing a prescription for suicide pills both constitute participation in the act. Waite-Simpson said that’s for the courts to decide.
“We’re looking to the judge. Does a referral constitute participation?” said Linda Waite-Simpson,
Betsy Walkerman, president of Patient Choices Vermont, says the case is about a patient’s right to information. Walkerman admits the law may force doctors to act against their religious conviction, but she argues that patients’ right to suicide in Vermont trumps the religious rights of doctors.
“They are entitled to complete information. All terminally ill Vermonters should be able to make informed choices,” she said, adding,“To understand that balance is something the court gets to decide.”
Both sides agree the case has long-term implications for the rights of doctors and patients alike. Aden said a ruling in favor of the state would be “an ominous step.”
“It will set the precedent that the commitments and values of providers can be set aside by the state, that the state can utterly change the nature of health care from healing to killing,” Aden said.
Waite-Simpson said a ruling for freedom of choice would “have very large implications” for other areas including stem cell transplants, blood transfusions and transgender treatment. “Patients may not be able to avail themselves of these services,” she said.
Vermont remains one of six states that have legalized physician assisted suicide. The other states include Oregon, Washington, California, Montana and Colorado.
As of May, doctors in Vermont have written 24 end-of-life prescriptions. It is not clear how many patients have used those prescriptions.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Seven thousand ninety awards can look like a victory lap until you remember how easily raw citation counts can be gamed. Clarivate’s 2026 Highly Cited Researchers list is more interesting for its insistence on screening than for the familiar names at the top. In a research world where publication volume, self-citation and paper mills have made plenty of people...
Continue Reading
Holiday panic is a thief's favorite crowbar, and Long Island households are plainly in the crosshairs. PSEG Long Island used Utility Scam Awareness Day on Nov. 18 to warn customers about impersonators demanding immediate payment under threat of a power shutoff. The central message, “Think Before You Scan,” is not flashy corporate wallpaper. It is practical advice for...
Continue Reading
A prototype is cheap theatre; keeping it alive after customers arrive is where the bill lands. CloudBackend has raised €6.6 million to attack that unglamorous, absolutely vital stretch between an AI-made app and an actual software business. The round is led by Carl-Henric Svanberg's family office, while existing backer M2 Asset Management increased its stake. That is a...
Continue Reading
A Policy Squeeze Is Rewriting the Battery Map Battery supply chains are getting shoved through a narrower gate, and that is exactly why this proposed deal deserves a hard look. The GrowHub Limited wants to acquire EnChem America, a Georgia-based lithium-ion battery electrolyte producer, and the timing is plainly built around Washington's push to reduce reliance on...
Continue Reading
Eight years is long enough to separate a useful science partner from a glossy slide deck, and Vertex’s decision to add four more years with Genomics deserves attention. This is not a splashy acquisition, nor is it a clean revenue number investors can plug into next quarter’s model. It is a deeper commitment to the slow, expensive, wonderfully unforgiving business of...
Continue Reading
Radiology has heard enough grand AI promises to fill a hospital basement, which makes Sectra's RSNA 2026 message refreshingly grounded. The Swedish imaging IT and cybersecurity company is putting its weight behind the unglamorous part of adoption: fitting AI into the daily diagnostic machinery without handing clinicians another awkward system to babysit. That is where...
Continue Reading
A €1,339 chair has no business pretending it is an impulse buy, which is exactly why LiberNovo’s Black Friday push deserves a closer look. The Hong Kong-based ergonomic-chair seller has rolled out its Black Friday sale across the European Union and United Kingdom, with the campaign ending November 30 at 23:59 CET in the EU and 23:59 GMT in the UK. This is a...
Continue Reading
Three Nods, One Very Practical Product Claim Windows rarely stir much excitement outside an architect’s specification binder, but Kawneer has put together a respectable run with its OptiQ Offset Fixed/Projected Series Window. On November 18, 2026, the architectural aluminum-systems maker said the product had won in the Windows and Doors category at both the 2026...
Continue Reading
A sales call dies twice when nobody turns the recording into practice. First it ends with the prospect, then it vanishes into a pile of transcripts, dashboards, and manager good intentions. Ambition’s new Call Intelligence feature is aimed squarely at that second failure. It brings Gong calls, transcripts, scorecards, and trackers into Ambition’s coaching workflow,...
Continue Reading
Los Angeles is cramming an awful lot of automotive ambition into one Thursday. AutoMobility LA opens November 19 at the Los Angeles Convention Center, one day before the LA Auto Show begins its November 20–29 public run. Yes, there will be coffee carts, awards, creators and the usual event confetti. But beneath that polished show-floor racket sits a fairly serious...
Continue Reading
Top 5 Most Recently Viewed Articles
Investigation of Easterly ROCMuni High Income Bond Fund Investors of the Easterly ROCMuni High Income Municipal Bond Fund are facing troubling times. Recently, the Portnoy Law Firm initiated an investigation regarding potential securities fraud associated with this investment vehicle. If you have lost money after investing in the Easterly ROCMuni High Income, it's...
Continue Reading
Understanding the Shift in Japanese Equities Japanese equities are experiencing a resurgence, and this transformation is hard to ignore. The landscape of investment in Japan is shifting rapidly, and for those keeping an eye on the developments, there are compelling reasons to be optimistic. For years, conventional thought had deemed Japan as a country facing overwhelming...
Continue Reading
Exploring the Pet Grooming Services Market Growth The pet grooming services market is witnessing a remarkable transformation, with anticipated growth projected to reach over USD 12.05 billion during the next decade. The rising phenomenon of pet ownership, coupled with the ongoing trend of humanization, is significantly influencing this expansion. The global market was...
Continue Reading
Class Action Lawsuit Filed Against Dow Inc. Pomerantz LLP has announced the filing of a significant class action lawsuit against Dow Inc. (NYSE: DOW) and certain high-ranking officials within the company. This legal move signals a definitive call to action for investors who may have been adversely affected by the company’s alleged misrepresentations and omissions...
Continue Reading
Revolutionizing Philanthropy: A New Challenge for MrBeast In an exciting initiative that aims to transform the landscape of modern philanthropy, the 144K Collective has reached out to the well-known YouTube personality and philanthropy leader Jimmy Donaldson, popularly known as MrBeast. This event, titled "144K Vs. The Beast," represents a novel approach to enhancing...
Continue Reading